Jaakko Tuomilehto Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

1/2022	Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry.
11/2021	Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
12/2017	Exome-wide association study of plasma lipids in >300,000 individuals.
1/2017	The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of Cardiology.
10/2015	Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
5/2015	Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.
11/2013	Discovery and refinement of loci associated with lipid levels.
11/2013	Common variants associated with plasma triglycerides and risk for coronary artery disease.
1/2012	Do statins interfere with lifestyle intervention in the prevention of diabetes in primary healthcare? One-year follow-up of the FIN-D2D project.
8/2010	Biological, clinical and population relevance of 95 loci for blood lipids.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaakko Tuomilehto Research Topics

Disease

122	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2002
43	Insulin Resistance 12/2023 - 02/2002
36	Hypertension (High Blood Pressure) 04/2024 - 01/2002
36	Obesity 12/2022 - 04/2004
36	Glucose Intolerance 01/2022 - 07/2003
31	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 02/2002
25	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2002
24	Stroke (Strokes) 01/2024 - 06/2002
22	Inflammation (Inflammations) 12/2023 - 04/2010
18	Coronary Disease (Coronary Heart Disease) 10/2023 - 12/2002
17	Dementia (Dementias) 01/2024 - 10/2002
16	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2023 - 05/2002
15	Prediabetic State (Prediabetes) 03/2023 - 09/2009
12	Overweight 01/2022 - 12/2002
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2008
10	Hyperglycemia 01/2022 - 01/2005
9	Ischemic Stroke 01/2024 - 09/2005
9	Body Weight (Weight, Body) 03/2023 - 12/2003
9	Dyslipidemias (Dyslipidemia) 01/2021 - 12/2002
8	Diabetes Mellitus 01/2024 - 01/2002
8	Cognitive Dysfunction 01/2024 - 09/2004
8	Weight Loss (Weight Reduction) 12/2022 - 01/2013
8	Myocardial Infarction 02/2013 - 01/2004
7	Abdominal Obesity 01/2018 - 06/2005
7	Isolated Systolic Hypertension 04/2012 - 10/2001
5	Hemorrhagic Stroke 01/2024 - 05/2009
5	Non-alcoholic Fatty Liver Disease 12/2023 - 05/2010
5	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023 - 08/2012
5	Fatty Liver 01/2023 - 06/2013
4	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2002
4	Heart Failure 10/2023 - 01/2004
4	Diabetes Complications 01/2023 - 01/2002
4	Chronic Disease (Chronic Diseases) 07/2018 - 07/2002
4	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2016 - 10/2010
4	Neoplasms (Cancer) 12/2014 - 09/2011
4	Heart Valve Diseases (Valvular Heart Disease) 02/2013 - 09/2010
3	Ankylosing Spondylitis 05/2015 - 08/2008
3	Hyperinsulinism (Hyperinsulinemia) 05/2010 - 05/2004
2	Genetic Risk Score 04/2024 - 10/2013

Drug/Important Bio-Agent (IBA)

126	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 05/2002
40	Insulin (Novolin)FDA Link 11/2023 - 12/2002
31	Antihypertensive Agents (Antihypertensives)IBA 07/2020 - 01/2002
28	CholesterolIBA 11/2023 - 01/2002
20	Triglycerides (Triacylglycerol)IBA 01/2023 - 11/2002
18	HDL CholesterolIBA 01/2023 - 05/2004
16	Biomarkers (Surrogate Marker)IBA 12/2023 - 04/2010
15	LipidsIBA 01/2019 - 01/2002
12	Coffee FDA Link 08/2020 - 03/2004
11	LDL CholesterolIBA 01/2022 - 12/2002
8	Acarbose FDA LinkGeneric 10/2021 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2018
7	Apolipoproteins E (ApoE)IBA 01/2024 - 08/2002
7	Blood Glucose (Blood Sugar)IBA 01/2023 - 04/2004
7	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2016
6	Liraglutide FDA Link 01/2022 - 02/2015
6	ApolipoproteinsIBA 01/2018 - 08/2002
5	AlbuminsIBA 10/2023 - 06/2014
5	oxidized low density lipoproteinIBA 01/2022 - 12/2002
5	AdiponectinIBA 07/2018 - 01/2011
5	Vitamin D FDA LinkGeneric 01/2017 - 10/2004
5	HDL LipoproteinsIBA 11/2013 - 12/2008
4	Metformin (Glucophage)FDA LinkGeneric 01/2024 - 07/2016
4	Nonesterified Fatty Acids (NEFA)IBA 12/2023 - 01/2018
4	CreatinineIBA 11/2023 - 11/2002
4	Uric Acid (Urate)IBA 11/2023 - 03/2006
4	UrocortinsIBA 01/2022 - 01/2019
4	Messenger RNA (mRNA)IBA 01/2022 - 09/2002
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2004
4	C-Reactive ProteinIBA 01/2021 - 06/2009
4	Hemoglobins (Hemoglobin)IBA 01/2019 - 01/2016
4	TeaIBA 12/2017 - 11/2007
4	25-hydroxyvitamin DIBA 01/2017 - 11/2013
4	Interleukin-6 (Interleukin 6)IBA 11/2009 - 07/2003
4	AntigensIBA 08/2009 - 05/2002
4	Enalapril FDA LinkGeneric 01/2007 - 10/2001
3	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2022 - 08/2008
3	indolepropionic acidIBA 11/2022 - 11/2017
3	NeuropeptidesIBA 01/2022 - 01/2021
3	C-PeptideIBA 01/2022 - 01/2020
3	SodiumIBA 12/2020 - 02/2002
3	EnzymesIBA 09/2020 - 05/2010
3	ORALIT (ORS)IBA 01/2020 - 10/2005
3	GlucosidasesIBA 01/2020 - 07/2014
3	Hormones (Hormone)IBA 10/2019 - 01/2012
3	PalmitatesIBA 01/2019 - 01/2018
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019 - 02/2013
3	CytokinesIBA 07/2018 - 07/2003
3	Dietary Fiber FDA Link 01/2018 - 12/2003
3	Lipoproteins (Lipoprotein)IBA 12/2017 - 05/2004
3	HLA-B Antigens (HLA-B)IBA 05/2015 - 08/2009
3	AntibodiesIBA 04/2013 - 08/2002
3	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 04/2012 - 10/2001
3	Indapamide FDA LinkGeneric 04/2009 - 08/2004
3	Rosuvastatin Calcium (Crestor)FDA Link 06/2005 - 12/2002
2	Docosahexaenoic AcidsIBA 01/2024 - 01/2023

Therapy/Procedure

21	Therapeutics 01/2023 - 10/2001
9	Glycemic Control 01/2021 - 01/2015
5	Injections 01/2022 - 02/2015
3	Cognitive Training 03/2022 - 06/2015
3	Diet Therapy (Therapy, Diet) 06/2007 - 01/2006